A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease. Rascol O, Medori R, Baayen C, Such P, et al. Mov Disord 2022 Feb 26. doi: 10.1002/mds.28970.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rascol O, Medori R, Baayen C, Such P, et al. A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease. Mov Disord 2022 Feb 26. doi: 10.1002/mds.28970.
PMID: 35218231